BenzingaSeptember 21, 2026 at 7:45 AM NYLast Month
Here’s How Much You Would Have Made Owning Cytokinetics Stock In The Last 15 Years
Cytokinetics (NASDAQ:CYTK) has outperformed the market over the past 15 years by 2.64% on an annualized basis producing an average annual return of 15.99%. Currently, Cytokinetics has a market capitalization of $9.70
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
